Yeung CM, Suhardi VJ, Varady NH, et al. - The present study was performed to assess all consecutive total joint arthroplasty (TJA) patients treated for prosthetic joint infection (PJI) between 1995 and 2018 by a single high-volume revision TJA surgeon. Researchers further explored microbial identities, antibiotic resistance, prior PJI, and musculoskeletal infectious disease (MSK ID) consultation. A total of 261 PJI patients (median age 66 years, interquartile range 57-75) were included in the study. The findings revealed minimal variations in microbial/antibiotic resistances for PJI over 20 years in a single institution, implying current standards of PJI treatment remain encouragingly valid in most cases. It was reported that MSK ID involvement was not correlated with lower reinfection risk overall; nevertheless, the risk of reinfection seemed to be somewhat lower with MSK ID involvement in patients with prior PJI.